GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTI BioPharma Corp (LTS:0RLB) » Definitions » Sale Of Business

CTI BioPharma (LTS:0RLB) Sale Of Business : €0.00 Mil (TTM As of Mar. 2023)


View and export this data going back to 2008. Start your Free Trial

What is CTI BioPharma Sale Of Business?

CTI BioPharma's sale of business for the three months ended in Mar. 2023 was €0.00 Mil. It means CTI BioPharma gained €0.00 Mil from selling business. CTI BioPharma's sale of business for the trailing twelve months (TTM) ended in Mar. 2023 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Dec. 2022 ), CTI BioPharma gained the same money from selling business in Mar. 2023 (€0.00 Mil).


CTI BioPharma Sale Of Business Historical Data

The historical data trend for CTI BioPharma's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTI BioPharma Sale Of Business Chart

CTI BioPharma Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CTI BioPharma Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CTI BioPharma Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CTI BioPharma Sale Of Business Related Terms

Thank you for viewing the detailed overview of CTI BioPharma's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


CTI BioPharma (LTS:0RLB) Business Description

Traded in Other Exchanges
N/A
Address
3101 Western Avenue, Suite 800, Seattle, WA, USA, 98121
CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

CTI BioPharma (LTS:0RLB) Headlines

No Headlines